- An independent panel of scientists have concluded Tamiflu and Relenza, two drugs used worldwide to treat swine flu only help reduce the symptoms by half a day, and contrary to their claims do not prevent dangerous complications such as pneumonia and transmission of virus, or reduce admissions to hospitals.
- Companies behind the drug had withheld critical information regarding their ineffectiveness during clinical trials.
- Evidences from trials also confirmed the increased risk of nausea and vomiting along with headaches, psychiatric disturbances and renal events associated with these drugs.
- Many countries including India have spent millions of dollars in stockpiling these 2 drugs to counter a possible swine flu pandemic. In light of this, The British Medical Journal and Cochrane have called on governments and health policy decision makers to review guidance on use of Tamiflu.
- Swine flu
- Ethics of Clinical Trials